Kiniksa Pharmaceuticals Ltd at Barclays Global Healthcare Conference Transcript
Barclay's Global Healthcare Conference. My name's Geoff Meacham. I'm the Senior Biopharma Analyst here. And it's my pleasure to have Kiniksa Pharmaceuticals presenting this morning. Speaking on behalf of Kiniksa and on stage here, we have Sanj Patel, who is CEO; and John Paolini, who is the Chief Medical Officer.
Sanj?
Thank you, Geoff. Good morning. It's good to be here. Thank you also to Barclays for hosting us today. We're excited to review our pipeline. As Geoff mentioned, John Paolini, our Chief Medical Officer, and I will review it in detail today. Incidentally, our mantra at Kiniksa is every second counts, so we're going to get right into it. Thank you.
Please note that we will be making forward-looking statements today that are subject to risks and uncertainties. A review of these risk factors and statements are on this slide as well as under the heading
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |